AXA S.A. - REATA PHARMACEUTICALS INC ownership

Back to all holdings Add to watchlist

REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 209 filers reported holding REATA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.53 and the average weighting 0.6%.

Links
Filings
External links
Quarter-by-quarter ownership
AXA S.A. ownership history of REATA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$245,484
-61.3%
2,700
-89.3%
0.00%0.0%
Q3 2022$633,638
-29.9%
25,200
+334.5%
0.00%
-50.0%
Q2 2020$904,000
-40.9%
5,800
-45.3%
0.00%
-50.0%
Q1 2020$1,530,000
+273.2%
10,600
+120.8%
0.00%
+100.0%
Q1 2019$410,000–4,800–0.00%–
 Download
Other shareholders
REATA PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
DekaBank Deutsche Girozentrale 17,000$2,9300.01%
PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO 93,711$1,6120.00%
IFP Advisors, Inc 300$51,7080.00%
View complete list of REATA PHARMACEUTICALS INC shareholders